Pure Global AI
Colombia INVIMA registration INVIMA 2024RD-0008928

AD-BIO PRUEBA RÁPIDA DEL VIRUS DE INMUNODEFICIENCIA HUMANA 1/2 (VIH 1/2) (SANGRE TOTAL /SUERO/PLASMA)(CASETE)

HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANYIIIColombia INVIMAExpires November 08, 2029
VerifiedINVIMA · official registry
Device classification
Registered product (Spanish)
AD-BIO PRUEBA RÁPIDA DEL VIRUS DE INMUNODEFICIENCIA HUMANA 1/2 (VIH 1/2) (SANGRE TOTAL /SUERO/PLASMA)(CASETE)
View exact product-name matches →
Risk class / Clase de riesgo
III
Product group (Spanish)
REACTIVO DIAGNOSTICO
View exact product-group matches →
Registration information
Sanitary registration
INVIMA 2024RD-0008928
Expediente
20284304
Status / Estado
Active
Expiry date
November 08, 2029
Registration holder / Titular
Name
ANNAR DIAGNOSTICA IMPORT S.A.S.
Associated party / Rol
Name
HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY
Role
FABRICANTE
Country
ESTADOS UNIDOS DE AMÉRICA
Manufacturer
HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY
About this record

Access comprehensive regulatory information for AD-BIO PRUEBA RÁPIDA DEL VIRUS DE INMUNODEFICIENCIA HUMANA 1/2 (VIH 1/2) (SANGRE TOTAL /SUERO/PLASMA)(CASETE) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA sanitary registration INVIMA 2024RD-0008928, held by ANNAR DIAGNOSTICA IMPORT S.A.S. and associated with HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY (FABRICANTE). The registration expires on November 08, 2029.

This page provides complete registration details including product group (REACTIVO DIAGNOSTICO), holder and associated-party information, and regulatory data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.